Northern Trust’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Northern Trust’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,323	Closed	-$218K	–	4777
2022 Q1	$218K	Sell	6,323 -767	-11%	-$27.1K	﹤0.01%	4103
2021 Q4	$311K	Buy	7,090 +90	+1%	+$4.26K	﹤0.01%	4007
2021 Q3	$355K	Sell	7,000 -500	-7%	-$26.1K	﹤0.01%	3904
2021 Q2	$390K	Hold	7,500	–	–	﹤0.01%	3823
2021 Q1	$343K	Sell	7,500 -500	-6%	-$24.4K	﹤0.01%	3932
2020 Q4	$368K	Hold	8,000	–	–	﹤0.01%	3804
2020 Q3	$312K	Hold	8,000	–	–	﹤0.01%	3708
2020 Q2	$304K	Buy	+8,000	New	+$270K	﹤0.01%	3657

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

Northern Trust's IDNA Position: Q2 2022 in Review

Northern Trust sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2022, closing a stake of 6,323 shares — an estimated $218K sold.

Northern Trust first reported a position in IDNA in Q2 2020 and held it in 8 quarters. The position peaked at $390K in Q2 2021. 73 funds tracked by Wall St. Rank hold IDNA as of Q2 2022.

Northern Trust reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2022 after selling out during the quarter.
Northern Trust sold 6,323 iShares Genomics Immunology and Healthcare ETF shares in Q2 2022, an estimated $218K.
Northern Trust first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 8 quarters.
Northern Trust's iShares Genomics Immunology and Healthcare ETF position peaked at $390K in Q2 2021.
73 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2022.

Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.